Changes related to "Diffuse large B-cell lymphoma"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 04:22, 21 September 2018
   
Page name:

17 September 2018

 m   22:15  Complex multipart regimens‎ (diff | hist) . . (+2). . Warner-admin (talk | contribs) (Text replacement - "Subset analysis''':" to "Subgroup analysis:'''")

16 September 2018

     21:43  Autologous HSCT‎ (diff | hist) . . (+2,292). . Jwarner (talk | contribs) (CBV {{#subobject:935235|Regimen=1}})
 m   19:47  Complex multipart regimens‎ (diff | hist) . . (+1,327). . Jwarner (talk | contribs) (Head and neck cancer)
 m   11:28  CNS lymphoma‎ (diff | hist) . . (+63). . PeterYang (talk | contribs) (CYVE {{#subobject:b2c919|Regimen=1}}: correction of etoposide dose)

14 September 2018

 m   09:50  Lenalidomide (Revlimid)‎ (diff | hist) . . (+1,027). . Jwarner (talk | contribs)